For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...

Seniors who engaged in memory strategies two hours a week had enduring thinking benefits, a new study suggests.

The failure to diagnose Alzheimer's disease—the most common form of dementia in the elderly—at an early stage of molecular ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...

New research suggests that familial risk of Alzheimer's disease may be higher depending on which parent is affected.

Meet others who can help you navigate the disease at the annual Walk to End Alzheimer's disease September 28th.

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...

Light pollution was more strongly correlated with Alzheimer’s disease than some other well-known risk factors.